The addition of an experimental Bristol-Myers Squibb biotech medicine to standard therapy for patients whose multiple myeloma has relapsed led to longer remissions and cut the risk of death over standard treatment alone, according to data from a late stage study. The drug, elotuzumab, which is being developed in collaboration with AbbVie, extended the […]

A mid-stage trial of Roche Holding AG’s experimental immunotherapy showed that it doubled the likelihood of survival for lung cancer patients with the highest levels of a specific biomarker. The drug, known by the code name MPDL3280A, is part of a new class designed to help the body’s immune system fend off cancer by blocking […]

A woman smokes outside a club in the trendy nightlife district of Hongdae in Seoul, May 8, 2015. Picture taken May 8, 2015. Reuters/Thomas Peter (Reuters Health) – Want to increase the odds that someone will quit smoking? Make them pay money up front – money they could lose if they relapse – and give […]

SAN DIEGO, May 13, 2015 /PRNewswire/ — GenomeDx Biosciences today announced that multiple studies featuring clinical data from the company’s Decipher platform will be presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and published in the 2015 ASCO Annual Meeting Proceedings. Four of the abstracts feature validation data for the […]

NEW YORK, May 13, 2015 /PRNewswire-USNewswire/ — TB Alliance and its partners announced the start of a clinical trial of a new regimen to treat extensively drug-resistant tuberculosis (XDR-TB.) It is the first study to test an all-oral drug regimen, comprised of drugs with minimal pre-existing resistance, that has the potential to shorten, simplify, and […]

SACRAMENTO, Calif., May 13, 2015 /PRNewswire/ — Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and Scientist Dr. Chris Yu this week presented what event organizers published as, “very promising” and “breakthrough” early cancer detection technology research results at the “2015 Nobel Prize Laureate Summit on Biomedical Science: Frontiers in Cancer Research” (NPLS) in Tianjin, […]

Literally millions of people take vitamins in the hopes that doing so will improve their health – but scientific evidence has pointed to vitamin supplementation being useless or worse. Beta carotene supplements may actually increase mortality, as might vitamin E and vitamin A. Other seemingly promising supplements, like fish oil for heart disease, have seen […]

Drug manufacturers have begun amassing enormous troves of human DNA in hopes of significantly shortening the time it takes to identify new drug candidates, a move some say is transforming the development of medicines. The efforts will help researchers identify rare genetic mutations by scanning large databases of volunteers who agree to have their DNA sequenced […]

Germany’s Merck KGaA said that experimental cancer drug evofosfamide, which it is jointly developing with Threshold Pharmaceuticals, won fast track status for the treatment of advanced pancreatic cancer from the U.S. Food and Drug Administration. Merck had licensed in evofosfamide, previously known as TH-302, from Threshold in 2012. The drug attacks body tissue that is […]

Two months ago, the biotechnology company Orexigen filed a patent claiming its weight-loss drug Contrave might prevent heart attacks based on the first 25% of data from an ongoing study. But the disclosure was improper, yielding protests from Steven Nissen, the Cleveland Clinic scientist running the study, Orexigen’s marketing partner, the Japanese drug giant Takeda, […]